IMMUNIC INC
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page)
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Daniel Vitt and Glenn Whaley, and each of them, his or her true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ DANIEL VITT | Director, Chief Executive Officer and President | February 22, 2024 |
| Daniel Vitt | ||
| /s/ GLENN WHALEY | Chief Financial Officer | February 22, 2024 |
| Glenn Whaley | ||
| /s/ DUANE D. NASH | Executive Chairman | February 22, 2024 |
| Duane D. Nash | ||
| /s/ TAMAR HOWSON | Director | February 22, 2024 |
| Tamar Howson | ||
| /s/ JOERG NEERMANN | Director | February 22, 2024 |
| Joerg Neermann | ||
| /s/ RICHARD RUDICK | Director | February 22, 2024 |
| Richard Rudick | ||
| /s/ BARCLAY A. PHILLIPS | Director | February 22, 2024 |
| Barclay A. Phillips | ||
| /s/ MARIA TORNSEN | Director | February 22, 2024 |
| Maria Tornsen | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.